Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan G Murphy

Showing results (331-340 of 415) with videos related to

Pageof 42
Sort By:
Clinical Genitourinary Cancer|November 28, 2022
Modern Active Surveillance in Prostate Cancer: A Narrative ReviewTrent A Pattenden, Dhanika Samaranayke, Andrew Morton, et al.
The Lancet. Oncology|May 13, 2018
[<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyMichael S Hofman, John Violet, Rodney J Hicks, et al.
BJU International|July 2, 2019
Detection and localisation of primary prostate cancer using <sup>68</sup> gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathologyArveen A Kalapara, Tatenda Nzenza, Henry Y C Pan, et al.
European Urology Focus|November 11, 2020
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of <sup>177</sup>Lu-PSMA-617 Prior to ProstatectomyNattakorn Dhiantravan, John Violet, Renu Eapen, et al.
BJU International|September 10, 2015
Training in minimally invasive surgery in urology: European Association of Urology/International Consultation of Urological Diseases consultationHenk van der Poel, Willem Brinkman, Ben van Cleynenbreugel, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2017
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for PsychopharmacologyOliver D Howes, Maria Rogdaki, James L Findon, et al.
European Urology|March 28, 2025
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive TreatmentElio Mazzone, Donato Cannoletta, Leonardo Quarta, et al.
European Urology|May 20, 2025
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysisElio Mazzone, Alice Thomson, David C Chen, et al.
BJU International|September 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of cliniciansTrent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, et al.
European Urology Oncology|April 13, 2025
An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled TrialPenelope Schofield, Stephen Quinn, Natalie Richards, et al.
Pageof 42

Showing results (331-340 of 415) with videos related to

Sort By:
Pageof 42
Clinical Genitourinary Cancer|November 28, 2022
Modern Active Surveillance in Prostate Cancer: A Narrative ReviewTrent A Pattenden, Dhanika Samaranayke, Andrew Morton, et al.
The Lancet. Oncology|May 13, 2018
[<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyMichael S Hofman, John Violet, Rodney J Hicks, et al.
BJU International|July 2, 2019
Detection and localisation of primary prostate cancer using <sup>68</sup> gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathologyArveen A Kalapara, Tatenda Nzenza, Henry Y C Pan, et al.
European Urology Focus|November 11, 2020
Clinical Trial Protocol for LuTectomy: A Single-arm Study of the Dosimetry, Safety, and Potential Benefit of <sup>177</sup>Lu-PSMA-617 Prior to ProstatectomyNattakorn Dhiantravan, John Violet, Renu Eapen, et al.
BJU International|September 10, 2015
Training in minimally invasive surgery in urology: European Association of Urology/International Consultation of Urological Diseases consultationHenk van der Poel, Willem Brinkman, Ben van Cleynenbreugel, et al.
Journal of Psychopharmacology (Oxford, England)|December 15, 2017
Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for PsychopharmacologyOliver D Howes, Maria Rogdaki, James L Findon, et al.
European Urology|March 28, 2025
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive TreatmentElio Mazzone, Donato Cannoletta, Leonardo Quarta, et al.
European Urology|May 20, 2025
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysisElio Mazzone, Alice Thomson, David C Chen, et al.
BJU International|September 11, 2023
Barriers and enablers of active surveillance for prostate cancer: a qualitive study of cliniciansTrent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, et al.
European Urology Oncology|April 13, 2025
An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled TrialPenelope Schofield, Stephen Quinn, Natalie Richards, et al.
Pageof 42